Published in Clin Nutr on April 01, 1983
Diet in the pathogenesis and treatment of inflammatory bowel diseases. Gastroenterology (2015) 1.40
Controlled trial of bowel rest and nutritional support in the management of Crohn's disease. Gut (1988) 1.29
Controlled trial comparing two types of enteral nutrition in treatment of active Crohn's disease: elemental versus polymeric diet. Gut (1991) 1.28
Polymeric enteral diets as primary treatment of active Crohn's disease: a prospective steroid controlled trial. Gut (1993) 1.06
Enteral nutrition in inflammatory bowel disease. Gut (1986) 0.97
Importance of nutrition in inflammatory bowel disease. World J Gastroenterol (2009) 0.96
Enteral nutrition as primary therapy in Crohn's disease. Gut (1994) 0.93
Comparison of amino acid v peptide based enteral diets in active Crohn's disease: clinical and nutritional outcome. Gut (1994) 0.87
To feed or not to feed? Are nutritional supplements worthwhile in active Crohn's disease? Gut (2006) 0.81
Total parenteral nutrition as primary treatment in Crohn's disease--RIP? Gut (1988) 0.81
Some psychological and physiological aspects of enteral nutrition. Gut (1986) 0.78
Clinical nutrition: 6. Management of nutritional problems of patients with Crohn's disease. CMAJ (2002) 0.76
Nutrition in Crohn's disease. Ann R Coll Surg Engl (1990) 0.75
Polymorphisms of interferon-λ4 and IL28B - effects on treatment response to interferon/ribavirin in patients with chronic hepatitis C. Aliment Pharmacol Ther (2013) 3.59
Wilson's disease in patients presenting with liver disease: a diagnostic challenge. Gastroenterology (1997) 3.52
Improving doctor-patient communication. Not an option, but a necessity. BMJ (1998) 3.00
Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study. Gut (2006) 2.53
Primary interferon resistance and treatment response in chronic hepatitis C infection: a pilot study. Lancet (2001) 2.40
Twice-weekly administration of peginterferon-alpha-2b improves viral kinetics in patients with chronic hepatitis C genotype 1. J Viral Hepat (2003) 2.33
Usefulness of physiologic dual-chamber pacing in drug-resistant idiopathic dilated cardiomyopathy. Am J Cardiol (1990) 2.20
Von Willebrand Factor as a new marker for non-invasive assessment of liver fibrosis and cirrhosis in patients with chronic hepatitis C. Aliment Pharmacol Ther (2013) 2.12
ESPEN Guidelines on Enteral Nutrition: Liver disease. Clin Nutr (2006) 2.11
Durability of SVR in chronic hepatitis C patients treated with peginterferon-α2a/ribavirin in combination with a direct-acting anti-viral. Aliment Pharmacol Ther (2013) 2.04
Postcremation diagnosis from an electric shaver. Lancet (2001) 2.02
Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases. Hepatology (2001) 1.92
Photodynamic therapy of nonresectable cholangiocarcinoma. Gastroenterology (1998) 1.86
[Prophylaxis, diagnosis and therapy of hepatitis C virus (HCV) infection: the German guidelines on the management of HCV infection]. Z Gastroenterol (2010) 1.76
Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt. Gut (2003) 1.76
The triad of erectile dysfunction, hypogonadism and the metabolic syndrome. Int J Clin Pract (2008) 1.69
Detection of the His1069Gln mutation in Wilson disease by rapid polymerase chain reaction. Ann Intern Med (1997) 1.64
Blunted thrombopoietin response to interferon alfa-induced thrombocytopenia during treatment for hepatitis C. Hepatology (1998) 1.62
Energy metabolism in acute and chronic renal failure. Am J Clin Nutr (1990) 1.60
Wilson disease in two consecutive generations: an exceptional family. Am J Gastroenterol (2001) 1.50
Hepatocellular carcinoma in Central Europe: prognostic features and survival. Gut (2001) 1.45
Membranes of the adrenal medulla. Behaviour of insoluble proteins of chromaffin granules on gel electrophoresis. Biochem J (1970) 1.41
Beneficial effect of pharmacological modulation of the GABAA-benzodiazepine receptor on hepatic encephalopathy in the rat: comparison with uremic encephalopathy. Hepatology (1991) 1.41
ESPEN guidelines for nutrition in liver disease and transplantation. Clin Nutr (1997) 1.40
[Hepatitis B and C: incidence and regional distribution of hospitalizations in Austria]. Wien Klin Wochenschr (2000) 1.40
High prevalence of the H1069Q mutation in East German patients with Wilson disease: rapid detection of mutations by limited sequencing and phenotype-genotype analysis. J Hepatol (2001) 1.33
Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver. J Hepatol (1989) 1.30
A sensitive radioenzymatic assay for adrenaline and noradrenaline in plasma. Br J Clin Pharmacol (1977) 1.17
Low sodium/high potassium diet for prevention of hypertension: probable mechanisms of action. Lancet (1981) 1.17
[Expert opinion on boceprevir- and telaprevir-based triple therapies of chronic hepatitis C]. Z Gastroenterol (2012) 1.17
Bovine splenic nerve: characterization of noradrenaline-containing vesicles and other cell organelles by density gradient centrifugation. J Physiol (1969) 1.14
Bone disease in vitamin D-deficient patients with Crohn's disease. Dig Dis Sci (1989) 1.11
Differential mechanisms of neuroprotection by 17 beta-estradiol in apoptotic versus necrotic neurodegeneration. J Neurosci (2001) 1.11
Long-term efficacy of physiologic dual-chamber pacing in the treatment of end-stage idiopathic dilated cardiomyopathy. Am J Cardiol (1992) 1.10
Prevalence and clinical importance of hypertransaminasaemia in coeliac disease. Eur J Gastroenterol Hepatol (1999) 1.10
Effects of brain-derived neurotrophic factor (BDNF) on glial cells and serotonergic neurones during development. J Neurochem (2005) 1.09
Long-term follow-up of chronic hepatitis C patients with sustained virological response to various forms of interferon-based anti-viral therapy. Aliment Pharmacol Ther (2006) 1.09
The relation of iron status and hemochromatosis gene mutations in patients with chronic hepatitis C. Gastroenterology (1999) 1.08
Letter: comparing scoring systems and outcome of patients admitted to a liver intensive care unit with severe variceal bleeding. Aliment Pharmacol Ther (2014) 1.07
The future of men and their health. BMJ (2001) 1.06
Bovine adrenal medulla: subcellular distribution of newly synthesised catecholamines, nucleotides and chromogranins. Naunyn Schmiedebergs Arch Pharmacol (1972) 1.06
Thrombopoietin induces rapid resolution of thrombocytopenia after orthotopic liver transplantation through increased platelet production. Blood (2000) 1.06
Hepatic encephalopathy in thioacetamide-induced acute liver failure in rats: characterization of an improved model and study of amino acid-ergic neurotransmission. Hepatology (1989) 1.06
AMPA receptor subunit 1 (GluR-A) knockout mice model the glutamate hypothesis of depression. FASEB J (2008) 1.05
The glutamate analogue alpha-aminoadipic acid is taken up by astrocytes before exerting its gliotoxic effect in vitro. J Neurosci (1984) 1.05
Is tube feeding with elemental diets a primary therapy of Crohn's disease? Klin Wochenschr (1984) 1.04
Effect of sex and gender on psychosocial aspects of prostate and breast cancer. BMJ (2001) 1.04
Membrane proteins of chromaffin granules, dopamine -hydroxylase, a major constituent. Biochem J (1972) 1.02
Neurological and neuropsychiatric spectrum of Wilson's disease: a prospective study of 45 cases. J Neurol (1991) 1.02
Successful HCV eradication and inhibition of HIV replication by intravenous silibinin in an HIV-HCV coinfected patient. J Clin Virol (2010) 1.01
Liver biopsy is a useful predictor of response to interferon therapy in chronic hepatitis C. Histopathology (1998) 1.00
Acidic colonic microclimate--possible reason for false negative hydrogen breath tests. Gut (1988) 1.00
Substance P is markedly increased in plasma of patients with hepatic coma. Lancet (1984) 1.00
Dental and periodontal disease in patients with cirrhosis--role of etiology of liver disease. J Hepatol (1995) 0.99
Suppression of haematopoiesis during therapy of chronic hepatitis C with different interferon alpha mono and combination therapy regimens. Gut (2005) 0.98
Improvement of hepatic encephalopathy treated with flumazenil. Lancet (1988) 0.98
Ornipressin in the treatment of functional renal failure in decompensated liver cirrhosis. Effects on renal hemodynamics and atrial natriuretic factor. Gastroenterology (1991) 0.98
The impact of apolipoprotein E genotypes on age at onset of symptoms and phenotypic expression in Wilson's disease. Brain (2000) 0.98
Implications of PNPLA3 polymorphism in chronic hepatitis C patients receiving peginterferon plus ribavirin. Aliment Pharmacol Ther (2012) 0.97
Screening for celiac disease: a prospective study on the value of noninvasive tests. Am J Gastroenterol (1995) 0.97
The activity of the sympathetic nervous system following severe head injury. Intensive Care Med (1980) 0.97
Predominance of the HLA-H Cys282Tyr mutation in Austrian patients with genetic haemochromatosis. J Hepatol (1997) 0.96
The impact of environmental enrichment on sex-specific neurochemical circuitries - effects on brain-derived neurotrophic factor and the serotonergic system. Neuroscience (2012) 0.96
Kainic acid-induced changes of serotonin and dopamine metabolism in the striatum and substantia nigra of the rat. Eur J Pharmacol (1981) 0.96
Prevention of bone mineral loss in patients with Crohn's disease by long-term oral vitamin D supplementation. Eur J Gastroenterol Hepatol (1995) 0.95
Partial pressure of ammonia versus ammonia in hepatic encephalopathy. Hepatology (2000) 0.95
Centrilobular necrosis in autoimmune hepatitis: a histological feature associated with acute clinical presentation. J Clin Pathol (2006) 0.95
A novel variant of lysosomal acid lipase in cholesteryl ester storage disease associated with mild phenotype and improvement on lovastatin. J Hepatol (1997) 0.94
Beneficial effect of 8-ornithin vasopressin on renal dysfunction in decompensated cirrhosis. Gut (1989) 0.94
The neuronal monoamine transporter VMAT2 is regulated by the trimeric GTPase Go(2). J Neurosci (2000) 0.94
Wilson's disease presenting in a family with an apparent dominant history of tremor. J Neurol Neurosurg Psychiatry (2001) 0.93
Long-term follow-up study of asymptomatic HBsAg-positive voluntary blood donors in Austria: a clinical and histologic evaluation of 242 cases. Hepatology (1987) 0.92
Salt sensitivity in humans is linked to enhanced sympathetic responsiveness and to enhanced proximal tubular reabsorption. Hypertension (1984) 0.91
Energy metabolism in patients with acute and chronic liver disease. Hepatology (1990) 0.91
Brain dysfunction in fulminant hepatic failure. J Hepatol (1994) 0.90
Obliterations of the proximal subclavian artery: to bypass or to anastomose? J Cardiovasc Surg (Torino) (1991) 0.90
Hydrolysis of a chymotrypsin substrate and of naphthol AS-D chloroacetate by human leukocyte granules. Blut (1973) 0.90
Bi-allelic presence of the interleukin-10 receptor 1 G330R allele is associated with cirrhosis in chronic HCV-1 infection. Genes Immun (2005) 0.90
Wilson's disease: evidence of subgroups derived from clinical findings and brain lesions. Neurology (1993) 0.90
Screening for Wilson's disease in patients with liver diseases by serum ceruloplasmin. J Hepatol (1997) 0.90
Pancreatic polypeptide, pancreatic glucagon and enteroglucagon in morbid obesity and following gastric bypass operation. Int J Obes (1986) 0.89
Serum levels of gamma-aminobutyric-acid-like activity in acute and chronic hepatocellular disease. Lancet (1983) 0.89
Efficacy and safety of antiviral therapy in patients with Crohn's disease and chronic hepatitis C. Aliment Pharmacol Ther (2008) 0.88
Stenosis of the common bile duct due to Ormond's disease: case report and review of the literature. J Hepatol (1999) 0.88
Prevalence and clinical significance of GB virus type C/hepatitis G virus coinfection in patients with chronic hepatitis C undergoing antiviral therapy. J Viral Hepat (2010) 0.87
Time gated fluorescence spectroscopy in Barrett's oesophagus. Gut (2003) 0.87
Successful long-term treatment of portal-systemic encephalopathy by the benzodiazepine antagonist flumazenil. Gastroenterology (1989) 0.87
Review article: genetic factors that modify the outcome of viral hepatitis. Aliment Pharmacol Ther (2014) 0.86
Recurrence of hepatitis B in children with serologic evidence of past hepatitis B virus infection undergoing antileukemic chemotherapy. J Hepatol (1989) 0.86
[Causal therapeutic management of aplastic anaemia (author's transl)]. Wien Klin Wochenschr (1981) 0.86
Changes of dopamine beta-hydroxylase activity in human plasma during prolonged overactivity of the sympathetic nervous system in various diseases. Naunyn Schmiedebergs Arch Pharmacol (1978) 0.86
25-hydroxyvitamin D absorption in patients with Crohn's disease and with pancreatic insufficiency. Wien Klin Wochenschr (1997) 0.86
Gamma-glutamyltranspeptidase (GGTP): its relationship to other enzymes for diagnosis of liver disease. Prog Liver Dis (1976) 0.85
Hepatocellular carcinoma in long-term sustained virological responders following antiviral combination therapy for chronic hepatitis C. J Viral Hepat (2008) 0.85